Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap

Core Viewpoint - Vektor Medical has received FDA 510(k) clearance for its next-generation vMap® technology, enhancing its capabilities in cardiac arrhythmia care [1] Group 1: Product Enhancements - The vMap technology now includes non-invasive mapping capabilities with several major enhancements [1] - New features include atrial flutter mapping and direct ECG and data streaming with electroanatomic mapping systems [1] - The technology allows for 3D model import and visualization, and it can be converted into a Software as a Medical Device (SaMD) [1]